The interplay between PEGylated nanoparticles and blood immune system

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Polyethylene glycol (PEG) modification of nanoparticles is common but can elicit immune responses.
• Accelerated blood clearance (ABC) and hypersensitivity reactions (HSR) to PEGylated nanoparticles limit their therapeutic efficacy and pose safety risks.
• Divergent results in published literature highlight the need for a clearer understanding of PEG immunogenicity.

Purpose of the Study:

• To elucidate the physiological mechanisms underlying PEG-specific immune responses.
• To explain contradictory findings regarding PEGylated nanoparticles and immune reactions.
• To discuss the influence of nanoparticle-associated factors on immune responses.

Main Methods:

• Review of existing literature on PEG immunogenicity, ABC, and HSR.
• Analysis of physiological mechanisms of PEG-specific immune responses.
• Speculation on the relationship between induction and effectuation phases of immune response.
• Classification of nanoparticle-associated factors based on action phase.

Main Results:

• Summarized physiological mechanisms of PEG-specific immune responses.
• Proposed a framework to explain divergent results concerning PEGylated nanoparticles.
• Discussed nanoparticle factors influencing immune responses.

Conclusions:

• A deeper understanding of PEG immunogenicity mechanisms is essential for designing safer PEGylated nanoparticles.
• Addressing PEG-specific immune responses can improve nanoparticle efficacy and patient safety.
• This review provides insights for developing strategies to mitigate unfavorable immune reactions to PEGylated nanomaterials.